Ningbo Highmomedical Technology Co.,Ltd -

Ningbo Highmomedical Technology Co.,Ltd

Showing 1 - 9 of 9, total 1 pages [First] [Previous] [Next] [Last]

ivabradine
Specification: 99%,
Detail: 866783-13-3 Ivabradine HCL Cas no 148849-67-6 (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane hydrochloride Cas No 866783-13-3 7,8-dimethoxy-1,3-dihydro-2H-3-Benzazepin-2-one Cas No 73942-87-7 7, 8-Dimethoxy-1,3,4,5-...

agomelatine
Specification: antidepression
Detail: is an antidepressant developed by the pharmaceutical co***ny Servier. It is marketed for the treatment of major depressive disorder and has been reported to have a reduced level of sexual side effects as well as discontinuatio...

dapoxetine
Specification: Enterprise standard
Detail: Dapoxetine was created by Eli Lilly and Co***ny and is credited to biochemist David T. Wong. Originally known as LY 210448, it was being developed by Lilly as an antidepressant. Eli Lilly sold the patent to Johnson & Johnson f...

sitagliptin
Specification: EP6.0
Detail: Sitagliptin, its intermediates ,

ivabradine
Specification: Enterprise standard
Detail: Ivabradine was approved by the European Medicines Agency in 2005. It is indicated for the symptomatic treatment of chronic stable angina pectoris in patients with normalsinus rhythm, who have a contraindication to or intoleran...

lincomycin hcl
Specification: GMP , EP;
Detail: Intramuscular administration of a single dose of 600 mg of Lincomycin produces average peak serum levels of 11.6 micrograms/ml at 60 minutes, and maintains therapeutic levels for 17 to 20 hours, for most susceptible gram-posit...

d-xylose
Specification: USP32
Detail: Xylose is the main building block for hemicellulose, which comprises about 30% of plant matter. Xylose is otherwise pervasive, being found in the embryos of most edible plants. It was first isolated from wood by Koch in 1881. ...

bortezomib
Specification: Enterprise standard
Detail: Bortezomib was originally synthesized in 1995 (MG-341) at a co***ny called Myogenics, which soon changed its name to ProScript. After promising preclinical results, the drug (PS-341) was tested in a small Phase I clinical tria...

silodosin
Specification: Enterprise standard
Detail: Since silodosin is a highly selective inhibitor of the ¦Á1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other ¦Á1 blockers). On the other side, the high selectivity seems to cause more...


Showing 1 - 9 of 9, total 1 pages [First] [Previous] [Next] [Last]
1